Mangangot, Jeanifer C.

HRN: 28-85-11  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
METRONIDAZOLE 500MG (TAB)
04/12/2026
04/18/2026
PO
500mg
TID
Amoebiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: